Vistagen shares are up 29% afterhours at $9.05 after the company disclosed in a regulatory filing that Commodore Capital has increased its stake by 776K shares of common stock, purchased on August 7th for about $18M.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on VTGN:
- Biotech Alert: Searches spiking for these stocks today
- VistaGen Therapeutics trading resumes
- VistaGen Therapeutics trading halted, volatility trading pause
- Vistagen upgraded to Buy at Maxim after SAD trial succeeds
- Vistagen upgraded to Buy from Hold at Maxim
Questions or Comments about the article? Write to editor@tipranks.com